What is the source omega-3 debate NOT about? November 20, 2011

Unfortunately, the debate is not about improving markets for omega-3 supplementation. It is not about the market space practically inventing complexity theory with all the new omega-3 forms coming out, possibly due to differentiation pressures and pharmaceutical claims demands. It is not about being incentivized to make adulterations to these native molecules, which get sliced and diced into new compounds.

The sources of omega-3 fatty acids is an academic discussion that is larger than any two or three companies or nations' laws for that matter, because it is not about any one core source of DHA+EPA or only one omega-3 fatty acid. It is not about omega-3s at all, or about who is a better citizen or a real oil, it is about serving society and following solid science.

For example, butter is scientifically better than margarine, but there are many more margarine products than butter. There has not been an improvement here, only modifications were made in these examples. So it is not about someone's new science being better than all other scientific consensus.   

It is not about the omega-3 issues in the EU that look confusing to anyone who is not an expert, and then the experts even get confused because negative marketing has increased everywhere and will likely cause undue suffering to many through this fit.

It is often difficult for the average person to know what the various omega-3 products do in terms of dietary advantages, as a supplement solution, or even how to use these for medical nutrition purposes. Education is needed, not misinformation. Biocare is needed, not bioscare. Omega-3s are a bioscience, not a biotechnology. Omega-3s are verified as medical food when used properly.

Source-Omega wants to do something planetary in size, it wants to help offset this by addressing the needs of people. That is why we are organizing our new Diabetes Prevention Services, a public health based consultancy.

"We are working for the long-term to improve the medical community's understanding of the causes of type-2-diabetes, what preventive measures are proven, and to aid in helping them to improve the nutritional health of people" said Dr Doughman, CEO. 

Source-Omega supports the efforts of Dr Scott D. Doughman, PhD., a well published and reliable omega-3 Lipidologist. Source-Omega is also helping by manufacturing and marketing a clinically-defined high-quality omega-3 source that is good for a diabetic.

Dr Doughman was the first ever to advocate algae oil omega-3 therapy for diabetics, first in publication, then in context, and both in terms of its safety profile and the therapeutic maintenance of plasma lipids, needed in many at risk populations.

Diabetes benefits have been suggested for high DHA omega-3 intake since the original discovery of omega-3s linking postprandial triglycerides to diabetes in the Inuit populations in Greenland in 1971. For 40 years the raw and clinical data have pointed to high DHA omega-3 intake as the most beneficial for diabetics.  Arctic food chains are higher in DHA than EPA for survival in cold weather. As the longest chain and the most unsaturated omega-3 and the most abundant in the human, the 1.2 grams DHA therapy is clearly suited to these benefits.

Source-Omega's academic review of the evidence-based literature shows a daily intake of 1.2 grams of DHA+EPA from algae oil delivers about 1.0 grams of bioavailable omega-3 from this Pure Source of Omega-3™ [In Submission].

There is a direct correlation between the amount of omega-3 one obtains and the benefits expected. The recognition of omega-3s indirectly as Cod Liver Oil goes back to before the Institute of Medicine. Just like the oldest product on the market, one Cod Liver Oil supplier recommends a daily dosage intake of 1.2 grams of omega-3s EPA+DHA from the sea. Similarly, Source-Omega recommends a daily dosage of 1.2 grams omega-3 DHA+EPA from virgin algae oil grown away from the sea. Virgin algae oil means untouched by seawater, separate from marine food chains. 

The omega-3 ratio differences between the two sources are comparable mainly through indirect references, but suggest these as fundamentally equal omega-3 intake strategies. That is, these same recommendations preceded modern clinical trials using Cod Liver Oil. Native results over time found by society show benefits at the 1.2 gram omega-3 dosage, which is innate to this optimized routine; raised by society, validated by science.  

Again, after modern clinical trials with cod, fish and algae oils, the data suggest the same long-term results are achieved, independent of time, place, source, or historical context. The only omega-3 deities presiding over the best Cod Liver Oil and virgin algae oils are 'time and dosage', because nothing has changed but the choice of sources and the increased need for omega-3 medical nutrition worldwide.

Each high quality source of omega-3 will deliver a near clinically identical endpoint as a long-term outcome. That means omega-3s are more like a computer than an amplifier, 'you get out what you put in, and you get what you pay for' versus 'does little, talks a lot'.

Each of the original cod, fish and algae oils from high quality suppliers are as close to omega-3 liberty as one gets; as close to medicine as one needs to be. As close to perfect as omega-3s are. And they are.

By Source-Omega, LLC